$tnya closed .67 up 2.20% on 1.93M shares. thats 0.92x avg volume, same light tape all week.
fed delivered dovish. spy new all time high +1.15%. xbi ripped +2.67% best day in weeks. ibb +2.31%. rate sensitive risk on assets got the bid.
tnya participated but lagged. +2.20% on a day xbi does +2.67% is underperformance. ideal tnya behavior on high beta sector days would be +5 to 8%. instead we got half the sector move. second straight day underperforming xbi. buyers showed up but not aggressively. sellers stayed active. compliance overhang still bleeding into the tape.
4 day recap:
•fri close .64
•mon close .69 (+8.27 rmat)
•tue close .67 (-3.23)
•wed close .65 (-2.57 fomc)
•thu close .67 (+2.20)
net from friday +4.7% matching xbi. pattern is 3 down day underperforms vs 1 up day underperform. tnya specific pressure is real. this stock needs a tnya specific catalyst to break out. macro tailwind alone wont do it.
the underlying setup keeps building though. institutional ownership 90.54%. q2 2026 flow was 33 buyers to 7 sellers with 141 new positions. blackrock, adar1, gsa capital, stonepine, marshall wace all built new stakes at prices between 55 and 80 cents this year. specialist biotech names not passive index buyers. they read the data and built while retail was giving up.
the price gap between what smart money is accumulating and where the tape trades keeps widening. either the tape catches up or institutions keep collecting at a discount that wont last.
next real catalyst window opens mid october with aha 2026 acceptance pr. conference is nov 6-9 in chicago. between now and then we get 4 weeks of macro digestion and thin volume chop in the 63 to 70 range.
hodl. nfa. #biovic
$tnya closed .67 up 2.20% on 1.93M shares. thats 0.92x avg volume, same light tape all week.
fed delivered dovish. spy new all time high +1.15%. xbi ripped +2.67% best day in weeks. ibb +2.31%. rate sensitive risk on assets got the bid.
tnya participated but lagged. +2.20% on a day xbi does +2.67% is underperformance. ideal tnya behavior on high beta sector days would be +5 to 8%. instead we got half the sector move. second straight day underperforming xbi. buyers showed up but not aggressively. sellers stayed active. compliance overhang still bleeding into the tape.
4 day recap:
•fri close .64
•mon close .69 (+8.27 rmat)
•tue close .67 (-3.23)
•wed close .65 (-2.57 fomc)
•thu close .67 (+2.20)
net from friday +4.7% matching xbi. pattern is 3 down day underperforms vs 1 up day underperform. tnya specific pressure is real. this stock needs a tnya specific catalyst to break out. macro tailwind alone wont do it.
the underlying setup keeps building though. institutional ownership 90.54%. q2 2026 flow was 33 buyers to 7 sellers with 141 new positions. blackrock, adar1, gsa capital, stonepine, marshall wace all built new stakes at prices between 55 and 80 cents this year. specialist biotech names not passive index buyers. they read the data and built while retail was giving up.
the price gap between what smart money is accumulating and where the tape trades keeps widening. either the tape catches up or institutions keep collecting at a discount that wont last.
next real catalyst window opens mid october with aha 2026 acceptance pr. conference is nov 6-9 in chicago. between now and then we get 4 weeks of macro digestion and thin volume chop in the 63 to 70 range.
hodl. nfa. #biovic